High-Sensitivity, High-Specificity Biplex Ov16/OVOC3261 Rapid Diagnostic Test
Research question
- An Ov16/OVOC3261 biplex IgG4 test, whereby we are confident that we can provide > 60% sensitivity and 99.8% specificity, as required by the TPP for Onchocerciasis Elimination Mapping.
- Demonstration that the Ov16/OVOC3261 biplex IgG4 test behaves at least as good with blood as with plasma/serum samples (notably a perceived weakness of the SD Ov16 RDT)
Study sites
Regional Study Site, United States
Completed
Implementation partner(s)